Symposium - Community & Social Research Theme - A community lens on the viral hepatitis cascade of care
Tracks
.
| Tuesday, August 14, 2018 |
| 4:00 PM - 5:30 PM |
| Hall M (Ground Floor) |
Details
Learning Objectives - What is the Cascade of Care, and why should we care?;
- How is the individual experience included in the Cascade of Care?;
- How can we respond in different or innovative ways to respond to the cascade of care gaps?;
- What is in the pipeline that might affect our future work
Speaker
Professor Carla Treloar
Scientia Professor, Centre for Social Research in Health and the Social Policy Research Centre
UNSW Sydney
Mr Sione Crawford
Chief Executive Officer
Harm Reduction Victoria
Who and What is missing from the hepatitis C treatment Cascade of Care?
4:05 PM - 4:20 PMBiography
Sione is the CEO of Harm Reduction Victoria, the state organisation representing people who use drugs and people who inject drugs. He has been working in community and peer based organisations for around fifteen years in a variety of roles from policy to peer education to management. Sione is keen to explore evolving roles for the peer workforce; not just in hepatitis C care but across the range of health and policy issues that affect us as people who use drugs.
Dr Jack Wallace
Senior Research Officer
Burnet Institute
Hepatitis B and the cascade of care: Testing vs screening vs diagnosis vs chronic infection vs infectious vs liver disease
4:20 PM - 4:35 PMBiography
I am a social researcher whose research looks at hepatitis B as an issue where the biomedical, social, cultural, economic and political interconnect, and investigates how viral hepatitis affects individuals and communities and shapes social relations and practices.
Ms Nafisa Yussf
Community Engagement Officer
Cancer Council Victoria
Hepatitis B and the cascade of care: Testing vs screening vs diagnosis vs chronic infection vs infectious vs liver disease
4:20 PM - 4:35 PMBiography
Nafisa Yussf is a Community Engagement Officer at Cancer Council Victoria, she works in the Screening, Early Detection and Immunisation team.
Nafisa's background is in community development and BBV/STIs health promotion; planning and delivering programs within a culturally diverse framework.
And she is currently undertaking her Masters of Public Health.
Ms Emily Adamson
Policy And Program Advisor
Cancer Council Victoria
Using Liver Cancer Prevention Messages To Scale Up Diagnosis Of People With Hepatitis B
4:35 PM - 4:50 PMBiography
Emily is the Program and Policy Advisor for the Screening, Early Detection and Immunisation team at
Cancer Council of Victoria. Her role drives the planning, coordination of program and policy advice in relation to HPV vaccination and the prevention of
liver cancer linked to hepatitis. Emily’s background is in health promotion and management, and program design with diverse and marginalised communities.
Panel Discussion
Panel Members: Michael Ninburg, Lynnaire Matthews, Sione Crawford, Jack Wallace, Jillian White, Nafisa Yussf , Daniel Gallant
4:50 PM - 5:30 PMBrief Overview
• How do we communicate what matters to people living with viral hepatitis?
• What research agenda emerges when we apply a community lens to the cascade of care?
• Can we imagine other ways to provide care when we look at the cascade of care through a community lens?
• How can we make the cascade of care relevant to people with viral hepatitis? And should we?
• What research agenda emerges when we apply a community lens to the cascade of care?
• Can we imagine other ways to provide care when we look at the cascade of care through a community lens?
• How can we make the cascade of care relevant to people with viral hepatitis? And should we?
Biography
Chair
Lynnaire Matthews
Hepatitis Nurse
The Hepatitis Foundation Of Nz
Michael Ninburg
Executive Director
World Hepatitis Alliance
